Antagonism of the protein kinase R pathway in human cells by rhesus cytomegalovirus

Stephanie J. Child, Sarah E. Hickson, Avraham Bayer, Daniel Malouli, Klaus Frueh, Adam P. Geballe

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

While cytomegalovirus (CMV) infections are often limited in host range by lengthycoevolution with a single host species, a few CMVs are known to deviate from this rule. For example, rhesus macaque CMV (RhCMV), a model for human CMV (HCMV) pathogenesis and vaccine development, can replicate in human cells, as well as in rhesus cells. Both HCMV and RhCMV encode species-specific antagonists of the broadly acting host cell restriction factor protein kinase R (PKR). Although the Rh- CMV antagonist of PKR, rTRS1, has very limited activity against human PKR, here, we show it is essential for RhCMV replication in human cells because it prevents human PKR from phosphorylating the translation initiation factor eIF2α, thereby allowing continued translation and viral replication. Although rTRS1 is necessary for RhCMV replication, it is not sufficient to rescue replication of HCMV lacking its own PKR antagonists in human fibroblasts. However, overexpression of rTRS1 in human fibroblasts enabled HCMV expressing rTRS1 to replicate, indicating that elevated levels or early expression of a weak antagonist can counteract a resistant restriction factor like human PKR. Exploring potential mechanisms that might allow RhCMV to replicate in human cells revealed that RhCMV makes no less double-stranded RNA than HCMV. Rather, in human cells, RhCMV expresses rTRS1 at levels 2 to 3 times higher than those of the HCMV-encoded PKR antagonists during HCMV infection. These data suggest that even a modest increase in expression of this weak PKR antagonist is sufficient to enable RhCMV replication in human cells.

Original languageEnglish (US)
Article numbere01793-17
JournalJournal of Virology
Volume92
Issue number6
DOIs
StatePublished - Mar 1 2018

Fingerprint

Cytomegalovirus
Macacine herpesvirus 3
protein kinases
Protein Kinases
Macaca mulatta
cells
antagonists
fibroblasts
Cytomegalovirus Vaccines
Fibroblasts
Human herpesvirus 5
Peptide Initiation Factors
Double-Stranded RNA
Host Specificity
double-stranded RNA
Cytomegalovirus Infections
vaccine development
virus replication

Keywords

  • Cytomegaloviruses
  • dsRNA
  • eIF2
  • Evolution
  • Protein kinase R
  • Species specificity

ASJC Scopus subject areas

  • Microbiology
  • Immunology
  • Insect Science
  • Virology

Cite this

Child, S. J., Hickson, S. E., Bayer, A., Malouli, D., Frueh, K., & Geballe, A. P. (2018). Antagonism of the protein kinase R pathway in human cells by rhesus cytomegalovirus. Journal of Virology, 92(6), [e01793-17]. https://doi.org/10.1128/JVI.01793-17

Antagonism of the protein kinase R pathway in human cells by rhesus cytomegalovirus. / Child, Stephanie J.; Hickson, Sarah E.; Bayer, Avraham; Malouli, Daniel; Frueh, Klaus; Geballe, Adam P.

In: Journal of Virology, Vol. 92, No. 6, e01793-17, 01.03.2018.

Research output: Contribution to journalArticle

Child, Stephanie J. ; Hickson, Sarah E. ; Bayer, Avraham ; Malouli, Daniel ; Frueh, Klaus ; Geballe, Adam P. / Antagonism of the protein kinase R pathway in human cells by rhesus cytomegalovirus. In: Journal of Virology. 2018 ; Vol. 92, No. 6.
@article{767dff01ca664694b7c9d78ab9419fd0,
title = "Antagonism of the protein kinase R pathway in human cells by rhesus cytomegalovirus",
abstract = "While cytomegalovirus (CMV) infections are often limited in host range by lengthycoevolution with a single host species, a few CMVs are known to deviate from this rule. For example, rhesus macaque CMV (RhCMV), a model for human CMV (HCMV) pathogenesis and vaccine development, can replicate in human cells, as well as in rhesus cells. Both HCMV and RhCMV encode species-specific antagonists of the broadly acting host cell restriction factor protein kinase R (PKR). Although the Rh- CMV antagonist of PKR, rTRS1, has very limited activity against human PKR, here, we show it is essential for RhCMV replication in human cells because it prevents human PKR from phosphorylating the translation initiation factor eIF2α, thereby allowing continued translation and viral replication. Although rTRS1 is necessary for RhCMV replication, it is not sufficient to rescue replication of HCMV lacking its own PKR antagonists in human fibroblasts. However, overexpression of rTRS1 in human fibroblasts enabled HCMV expressing rTRS1 to replicate, indicating that elevated levels or early expression of a weak antagonist can counteract a resistant restriction factor like human PKR. Exploring potential mechanisms that might allow RhCMV to replicate in human cells revealed that RhCMV makes no less double-stranded RNA than HCMV. Rather, in human cells, RhCMV expresses rTRS1 at levels 2 to 3 times higher than those of the HCMV-encoded PKR antagonists during HCMV infection. These data suggest that even a modest increase in expression of this weak PKR antagonist is sufficient to enable RhCMV replication in human cells.",
keywords = "Cytomegaloviruses, dsRNA, eIF2, Evolution, Protein kinase R, Species specificity",
author = "Child, {Stephanie J.} and Hickson, {Sarah E.} and Avraham Bayer and Daniel Malouli and Klaus Frueh and Geballe, {Adam P.}",
year = "2018",
month = "3",
day = "1",
doi = "10.1128/JVI.01793-17",
language = "English (US)",
volume = "92",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "6",

}

TY - JOUR

T1 - Antagonism of the protein kinase R pathway in human cells by rhesus cytomegalovirus

AU - Child, Stephanie J.

AU - Hickson, Sarah E.

AU - Bayer, Avraham

AU - Malouli, Daniel

AU - Frueh, Klaus

AU - Geballe, Adam P.

PY - 2018/3/1

Y1 - 2018/3/1

N2 - While cytomegalovirus (CMV) infections are often limited in host range by lengthycoevolution with a single host species, a few CMVs are known to deviate from this rule. For example, rhesus macaque CMV (RhCMV), a model for human CMV (HCMV) pathogenesis and vaccine development, can replicate in human cells, as well as in rhesus cells. Both HCMV and RhCMV encode species-specific antagonists of the broadly acting host cell restriction factor protein kinase R (PKR). Although the Rh- CMV antagonist of PKR, rTRS1, has very limited activity against human PKR, here, we show it is essential for RhCMV replication in human cells because it prevents human PKR from phosphorylating the translation initiation factor eIF2α, thereby allowing continued translation and viral replication. Although rTRS1 is necessary for RhCMV replication, it is not sufficient to rescue replication of HCMV lacking its own PKR antagonists in human fibroblasts. However, overexpression of rTRS1 in human fibroblasts enabled HCMV expressing rTRS1 to replicate, indicating that elevated levels or early expression of a weak antagonist can counteract a resistant restriction factor like human PKR. Exploring potential mechanisms that might allow RhCMV to replicate in human cells revealed that RhCMV makes no less double-stranded RNA than HCMV. Rather, in human cells, RhCMV expresses rTRS1 at levels 2 to 3 times higher than those of the HCMV-encoded PKR antagonists during HCMV infection. These data suggest that even a modest increase in expression of this weak PKR antagonist is sufficient to enable RhCMV replication in human cells.

AB - While cytomegalovirus (CMV) infections are often limited in host range by lengthycoevolution with a single host species, a few CMVs are known to deviate from this rule. For example, rhesus macaque CMV (RhCMV), a model for human CMV (HCMV) pathogenesis and vaccine development, can replicate in human cells, as well as in rhesus cells. Both HCMV and RhCMV encode species-specific antagonists of the broadly acting host cell restriction factor protein kinase R (PKR). Although the Rh- CMV antagonist of PKR, rTRS1, has very limited activity against human PKR, here, we show it is essential for RhCMV replication in human cells because it prevents human PKR from phosphorylating the translation initiation factor eIF2α, thereby allowing continued translation and viral replication. Although rTRS1 is necessary for RhCMV replication, it is not sufficient to rescue replication of HCMV lacking its own PKR antagonists in human fibroblasts. However, overexpression of rTRS1 in human fibroblasts enabled HCMV expressing rTRS1 to replicate, indicating that elevated levels or early expression of a weak antagonist can counteract a resistant restriction factor like human PKR. Exploring potential mechanisms that might allow RhCMV to replicate in human cells revealed that RhCMV makes no less double-stranded RNA than HCMV. Rather, in human cells, RhCMV expresses rTRS1 at levels 2 to 3 times higher than those of the HCMV-encoded PKR antagonists during HCMV infection. These data suggest that even a modest increase in expression of this weak PKR antagonist is sufficient to enable RhCMV replication in human cells.

KW - Cytomegaloviruses

KW - dsRNA

KW - eIF2

KW - Evolution

KW - Protein kinase R

KW - Species specificity

UR - http://www.scopus.com/inward/record.url?scp=85042469389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042469389&partnerID=8YFLogxK

U2 - 10.1128/JVI.01793-17

DO - 10.1128/JVI.01793-17

M3 - Article

C2 - 29263260

AN - SCOPUS:85042469389

VL - 92

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 6

M1 - e01793-17

ER -